Abstract

AbstractThe heptapeptide H‐MeBmt‐Abu‐Sar‐MeLeu‐Val‐MeLeu‐Ala‐OBzl (20) was synthesized for coupling with the previously described cyclosporine tetrapeptide sequence Boc‐D‐Ala‐MeLeu‐MeVal‐OH (21). The product of the coupling, the undecapeptide Boc‐D‐Ala‐MeLeu‐MeLeu‐MeVal‐MeBmt‐abu‐Sar‐MeLeu‐Val‐MeLeu‐Ala‐OBzl (22), was then deprotected and cyclized to cyclosporine (1).The tetrapeptide diastereoisomer Boc‐D‐ala‐MeLeu‐MeLeu‐D‐MeVAl‐OH (23) could also be used as a starting material to produce selectively the desired undecapeptide 22. In this case, the N‐methyl‐D‐valine unit, was selectively isomerized to the L‐from by using the appropriate condensing agent. The diastereoisomeric undecapeptide Boc‐D‐ala‐MeLeu‐MeLeu‐D‐MeVal‐MeBmt‐Abu‐Sar‐MeLeu‐Val‐MeLeuAla‐OBzl (24) was also synthesized starting from 21 by using the mixed pivalic anhydride method to selectively invert the configuration of the N‐methyl‐L‐valine. The structure of the undecapeptide 24 was confirmed by deprotection and cyclization to ‘cyclosporin H’, a natural product known to have the structure [D‐MeVal11]cyclosporine (2).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.